🇺🇸 FDA
Pipeline program

A study to assess the effect of single and repeated doses of JNJ-81241459 on a single dose of certain other drugs, when given together to healthy adult participants

Phase 1 other active

Quick answer

A study to assess the effect of single and repeated doses of JNJ-81241459 on a single dose of certain other drugs, when given together to healthy adult participants for Plaque Psoriasis is a Phase 1 program (other) at Janssen-Cilag International N.V. with 1 ClinicalTrials.gov record(s).

Program details

Company
Janssen-Cilag International N.V.
Indication
Plaque Psoriasis
Phase
Phase 1
Modality
other
Status
active

Clinical trials